The global market of Vitamin Bx (D-Calpan) has observed a decisive recovery in May xxxx and reversed the pronounced price corrections observed in April. The month was marked by a synchronized effort from suppliers to regain control over market prices through strategic supply moderation and calibrated export offers.
This move has effectively revived downstream demand of Vitamin Bx in the pharmaceutical, nutraceutical and food & beverage sectors. The improved offtake of end-user formulations including multivitamin blends, clinical nutrition products, fortified beverages and topical healthcare solutions has contributed to this demand revival. The buyers in key markets who had aggressively liquidated inventories in April ahead of new production cycles returned to the market with replenishment requirements and supported a positive price trajectory throughout May.
A significant inventory clearance by Vitamin Bx manufacturers took place in April as they prepared for...
